About the Coalition
The global, multisectoral Coalition for Access to NCD Medicines & Products was launched in 2017. This Coalition of government agencies, private-sector entities, nongovernmental organizations, philanthropic foundations, and academic institutions is dedicated to increasing access to medicines and health products for noncommunicable diseases (NCDs) to reduce the impact of diseases such as diabetes, hypertension, and cardiovascular disease.
Stay Up to Date
Global Health Leaders Unite in Their Commitment to Advance Investments and Solutions that Increase Equitable Access to Care for Noncommunicable Diseases
At the Coalition for Access to NCD Medicines and Products’ Annual Meeting, which took place in Kampala, Uganda in June, more than 100 leaders from government, civil society, academia, and industry reaffirmed a powerful message: even in times of crisis, investing in people’s health is not optional—it’s essential. With noncommunicable diseases (NCDs) driving the majority of preventable deaths worldwide, meeting attendees called for smarter, more efficient investments in primary health care, supply chains, and data systems to make NCD care more accessible; ensure adequate availability of NCD medicines and products at last mile; and gather more reliable data for decision-making. As we head toward the 4th United Nations High-Level Meeting on NCDs this September, we are united in our commitment to champion practical solutions, spotlight country-led progress, and advance innovations that show what’s possible when health remains a priority. Check out our Meeting Action Report to learn more.
UNGA79 Side Event
Alongside UNGA79, the Coalition and PATH united key stakeholders to drive action for integrated PHC, ensuring no one is left behind, including those with NCDs and mental illness. Proven tools exist to improve NCD care, and we must collaborate across sectors to secure adequate investment. As we look ahead to the G20 Summit and the High-Level Meeting on NCDs and Mental Illness, we’re eager to continue advocating for holistic primary health care.
Reflections on the 2nd Global Dialogue on Sustainable Financing for NCDs and Mental Health
Coalition members’ reflections from the dialogues are featured in our contribution to the World Hypertension League’s quarterly newsletter, September 2024 edition.
Diabetes Supplies: Are they there when needed?
A global review of the availability and affordability of the 22 essential medicines and technologies for comprehensive diagnosis and treatment of diabetes, hypertension, and dyslipidemia in low-resource settings. A publication from the “No Empty Shelves: Diabetes Supplies, There When Needed” Project.
Hear from our expert members
COVID-19
The Coalition’s blog series on COVID-19 and access to NCD medicines and products:
- NCD Medicines and Products – Not Just Resource Limited, but Resource Variable
- Improving Access to NCD Medicines and Products Will Help Build Future Pandemic Resilience
- Taking Critical Action on NCDs during the COVID-19 Response and Beyond
- Exacerbated Supply Chain Challenges During the COVID-19 Crisis & Creative Solutions that Bring Hope for People Living with NCDs
Check out these tools and resources from the World Health Organization and the NCD Alliance to learn more about COVID-19 & NCDs.
